Evidence map›Paper›PMID 27441645›Full record

ArticlePloS one2016

Improvement of ENU Mutagenesis Efficiency Using Serial Injection and Mismatch Repair Deficiency Mice.

Jabier Gallego-Llamas, Andrew E Timms, Rose Pitstick, Janet Peters, George A Carlson, David R Beier

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jabier Gallego-LlamasCenter for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, United States of America.
Andrew E TimmsCenter for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, United States of America.
Rose PitstickMcLaughlin Research Institute, Great Falls, MT, United States of America.
Janet PetersMcLaughlin Research Institute, Great Falls, MT, United States of America.
George A CarlsonMcLaughlin Research Institute, Great Falls, MT, United States of America.
David R BeierCenter for Developmental Biology and Regenerative Medicine, Seattle Children's Research Institute, Seattle, WA, United States of America.ORCID http://orcid.org/0000-0002-0325-8520
McLaughlin Research Institute · USSeattle Children's Hospital · US

Funding

TRANSGENETICS OF CHIMERIC PROTEINS IN PRION REPLICATION &DISEASEP01NS041997 · NINDS · MC LAUGHLIN RESEARCH INSTITUTE · PI DEARMOND, STEPHEN J. · 2001 to 2011
$15.0M
Mutagenesis and Murine Embyonic DevelopmentR01HD036404 · NICHD · SEATTLE CHILDREN'S HOSPITAL · PI BEIER, DAVID R. · 1998 to 2020
$8.1M
Analysis of neurodevelopment using mouse mutagenesisR01MH081187 · NIMH · SEATTLE CHILDREN'S HOSPITAL · PI BEIER, DAVID R. · 2008 to 2012
$2.4M
Mutant mapping and identification in zebrafish by next generation sequencingR01DK095721 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BEIER, DAVID R., GOESSLING, WOLFRAM · 2012 to 2016
$1.9M
NICHD NIH HHS R01 HD036404NIMH NIH HHS R01 MH081187NINDS NIH HHS P01 NS041997
6 · The paper itself

Abstract

ENU mutagenesis is a powerful method for generating novel lines of mice that are informative with respect to both fundamental biological processes and human disease. Rapid developments in genomic technology have made the task of identifying causal mutations by positional cloning remarkably efficient. One limitation of this approach remains the mutation frequency achievable using standard treatment protocols, which currently generate approximately 1-2 sequence changes per megabase when optimized. In this study we used two strategies to attempt to increase the number of mutations induced by ENU treatment. One approach employed mice carrying a mutation in the DNA repair enzyme Msh6. The second strategy involved injection of ENU to successive generations of mice. To evaluate the number of ENU-induced mutations, single mice or pooled samples were analyzed using whole exome sequencing. The results showed that there is considerable variability in the induced mutation frequency using these approaches, but an overall increase in ENU-induced variants from one generation to another was observed. The analysis of the mice deficient for Msh6 also showed an increase in the ENU-induced variants compared to the wild-type ENU-treated mice. However, in both cases the increase in ENU-induced mutation frequency was modest.

Indexed as

AnimalsBase PairingBreedingDNA Mismatch RepairEthylnitrosoureaFemaleFertilityMice, Inbred C57BLMice, Inbred ICRMutagenesisMutationSurvival AnalysisEthylnitrosourea

Identifiers

PMID27441645
PMCPMC4956170
OpenAlexW2505391389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.